H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)

April 21, 2026 6:36 AM

H.C. Wainwright analyst Mitchell S. Kapoor reiterated a Buy rating and $50.00 price target on Legend Biotech Corp. (NASDAQ: LEGN).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found